Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lopez-Berestein

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Oncogene|October 24, 2017
Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)T Mitamura, S Pradeep, M McGuire, et al.
Oncogene|September 23, 2008
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liverM J Gray, N A Dallas, G Van Buren, et al.
Oncogene|May 6, 2020
Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liverM J Gray, N A Dallas, G Van Buren, et al.
Oncogene|January 5, 2016
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progressionR Rupaimoole, C Ivan, D Yang, et al.
Oncogene|July 28, 2015
Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancerZ Timsah, Z Ahmed, C Ivan, et al.
Oncogene|February 3, 2015
Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancerE G Seviour, V Sehgal, Y Lu, et al.
Oncogene|August 11, 2015
Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesisA S Nagaraja, P L Dorniak, N C Sadaoui, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 5, 2001
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycosesJ H Rex, T J Walsh, M Nettleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trialG N Hortobagyi, N T Ueno, W Xia, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Oncogene|October 24, 2017
Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)T Mitamura, S Pradeep, M McGuire, et al.
Oncogene|September 23, 2008
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liverM J Gray, N A Dallas, G Van Buren, et al.
Oncogene|May 6, 2020
Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liverM J Gray, N A Dallas, G Van Buren, et al.
Oncogene|January 5, 2016
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progressionR Rupaimoole, C Ivan, D Yang, et al.
Oncogene|July 28, 2015
Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancerZ Timsah, Z Ahmed, C Ivan, et al.
Oncogene|February 3, 2015
Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancerE G Seviour, V Sehgal, Y Lu, et al.
Oncogene|August 11, 2015
Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesisA S Nagaraja, P L Dorniak, N C Sadaoui, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 5, 2001
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycosesJ H Rex, T J Walsh, M Nettleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trialG N Hortobagyi, N T Ueno, W Xia, et al.
Pageof 13